The Hellenic Network of Precision Medicine on Cancer was founded on 17/05/2018 at the initiative of the Research and Innovation Department of the Ministry of Education, Research and Religion in close collaboration with the Ministry of Health.

The Network is funded by the Framework of the Hellenic Republic – Siemens Settlement Agreement.

PATIENTS

5527 medical examinations until 31/10/2021

improved outlook and quality of life

collaboration with the Hellenic Cancer Federation

HEALTHCARE SYSTEM

standardization of procedures, completion of inter-laboratory checks

review of 7 reference laboratories

upgrade of clinical practices and promotion of digitized health

modern e-Referrals system, database, national repository for cancer genomic data

BIOSCIENTISTS

development of new tools and workflows, institutional framework for research studies

new prospects for research and cooperation through access to a large volume of biodata. Collaboration with: Hellenic Society of Medical Oncology (HeSMO), Hellenic Society of Haematology, Hellenic Society of Pathology.

WORK AND EDUCATION

45 new highly skilled job positions

appealing motives for Greek scientists living abroad

development of new specializations in Biology, Bioinformatics and Pharmacology

utilization of graduate students and motivation to attract teaching staff from abroad

INDUSTRY

Development of software and advanced diagnostic products. Collaboration interest from Biotechnology companies and diagnostic lab (e.g.):
ΑΝΤΙΣΕΛ ΑΕ
SafeBlood Bioanalytica
ΒΑΡΕΛΑΣ ΑΕ
GENEKOR
ΓΕΝΟΤΥΠΟΣ

PHARMACEUTICAL INDUSTRY

institutional framework for cooperation

collaboration in real-world clinical practices and early-access projects. For example:
Pharma Innovation Forum
Janssen
Novartis
Gilead
Abbvie
Roche
Astrazeneca

LATEST NEWS

Press release (in Greek) regarding the webinar ...

δείτε περισσότερα

Hellenic Cancer Federation webinar: European re...

δείτε περισσότερα

Hematologic cancer webinar

δείτε περισσότερα

PARTNERS